Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Mobile ECG Devices Market, by Modality
1.4.2 North America Mobile ECG Devices Market, by End-use
1.4.3 North America Mobile ECG Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Approvals
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Apr – 2023, Oct) Leading Players
4.4 Porter’s Five Force Analysis
Chapter 5. North America Mobile ECG Devices Market, by Modality
5.1 North America Handheld Market, by Country
5.2 North America Band Market, by Country
5.3 North America Pen Market, by Country
5.4 North America Others Market, by Country
Chapter 6. North America Mobile ECG Devices Market, by End-use
6.1 North America Hospitals & Diagnostic Centers Market, by Country
6.2 North America Ambulatory Care Market, by Country
6.3 North America Homecare Market, by Country
Chapter 7. North America Mobile ECG Devices Market, by Country
7.1 US Mobile ECG Devices Market
7.1.1 US Mobile ECG Devices Market, by Modality
7.1.2 US Mobile ECG Devices Market, by End-use
7.2 Canada Mobile ECG Devices Market
7.2.1 Canada Mobile ECG Devices Market, by Modality
7.2.2 Canada Mobile ECG Devices Market, by End-use
7.3 Mexico Mobile ECG Devices Market
7.3.1 Mexico Mobile ECG Devices Market, by Modality
7.3.2 Mexico Mobile ECG Devices Market, by End-use
7.4 Rest of North America Mobile ECG Devices Market
7.4.1 Rest of North America Mobile ECG Devices Market, by Modality
7.4.2 Rest of North America Mobile ECG Devices Market, by End-use
Chapter 8. Company Profiles
8.1 New York Plastic Surgical Group, PC (Long Island Plastic Surgical Group, PC)
8.1.1 Company Overview
8.1.2 SWOT Analysis
8.2 Nihon Kohden Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Product Category and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 GE HealthCare Technologies, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.3.6 SWOT Analysis
8.4 Medtronic PLC
8.4.1 Company overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Trials and Approvals:
8.4.5.2 Partnerships, Collaborations, and Agreements:
8.4.6 SWOT Analysis
8.5 iRhythm Technologies, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.5.4 Recent strategies and developments:
8.5.4.1 Trials and Approvals:
8.5.5 SWOT Analysis
8.6 Koninklijke Philips N.V.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Product Launches and Product Expansions:
8.6.5.2 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Omron Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Product Launches and Product Expansions:
8.7.5.2 Partnerships, Collaborations, and Agreements:
8.7.6 SWOT Analysis
8.8 AliveCor, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Product Launches and Product Expansions:
8.8.2.3 Trials and Approvals:
8.8.3 SWOT Analysis
8.9 EMAY
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. Nureca Limited (Dr Trust)
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Recent strategies and developments:
8.10.3.1 Product Launches and Product Expansions:
8.10.4 SWOT Analysis
Unique Offerings 